The Jewel in the federal crown?: History, politics, and the National Institutes of Health

History and Health Policy in the United States: Putting the Past Back In

Volumn 9780813539874, Issue , 2006, Pages 176-201

  Cook Deegan, Robert ^a   McGeary, Michael ^b  

^a DUKE UNIVERSITY   (United States)

^b Institute of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36749015940     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Abramson, John. 2004. Overdoéd America: The Broken Promise of American Medicine. New York: HarperCollins.
2. Angell, Marcia. 2004. The Truth About Drug Companies: How They Deceive Us and What to Do About It. New York: Random House.
3. Avorn, Jerry. 2004. Powerful Medicines: Benefits, Risks, and Costs of Prescription Drugs. New York: Alfred Knopf.
4. Baxter, James Phinney. 1946. Scientists against Time. Boston: Little, Brown.
5. Bush, Vannevar. 1945. Science-the Endless Frontier. Washington, DC: Office of Scientific Research and Development.
6. -. 1970. Pieces of the Action. New York: William Morrow.
7. Callahan, Daniel. 2003. What Price Better Health? Hazards of the Research Imperative. Berkeley: University of California Press.
8. Cockburn, Iain, and Rebecca M. Henderson. 1998. Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery. Journal of Industrial Economics 46, no. 2:157-182.
9. -. 1996. Public-Private Interaction in Pharmaceutical Research. Proceedings of the National Academy of Sciences 93:12725-12730.
10. Cohen, Wesley M., and John P. Walsh. 2002. Public Research, Patents and Implications for Industrial R&D in the Drug, Biotechnology, Semiconductor and Computer Industries. In Capitalizing on New Needs and New Opportunities: Government-Industry Partnerships in Biotechnology and Information Technologies, ed. C. W. Wessner, 223-243. Washington, DC: National Academy Press.
11. Department of Health, Education, and Welfare (DHEW). 1955. Annual Report of the U. S. Department of Health, Education, and Welfare. Washington, DC: U. S. Government Printing Office.
12. Department of Health and Human Services (DHHS). 2005a. Interim Final Rule, Supplemental Standards of Ethical Conduct and Financial Disclosure Requirements for Employees of the Department of Health and Human Services. Federal Register 70:5543-5565.
13. -. 2005b. FY 2006 Budget in Brief. www.dhhs.gov/budget/06budget/FY2006BudgetinBrief.pdf (accessed 27 June 2005).
14. Drew, Elizabeth. 1967. The Health Syndicate: Washington's Noble Conspirators. Atlantic Monthly, December, 75-82.
15. England, J. Merton. 1982. A Patron for Pure Science: The National Science Foundation's Formative Years, 1945-57. Washington, DC: National Science Foundation.
16. Fabrizio, Kira R. 2005. Absorptive Capacity and Innovation: Evidence from Pharmaceutical and Biotechnology Firms. Unpublished working paper, Haas School of Business, University of California, Berkeley.
17. Fossum, Donna, L. S. Painter, E. Eiseman, E. Ettedgui, and D. M. Adamson. 2004. Vital Assets: Federal Investment in Research and Development at the Nation's Universities and Colleges. Arlington, VA: RAND.
18. Fox, Daniel M. 1987. The Politics of the NIH Extramural Program, 1937-1950. Journal of the History of Medicine and Allied Sciences 42:447-466.
19. Gambardella, Alfonso 1995. Science and Innovation: The U. S. Pharmaceutical Industry during the 1980s. New York: Cambridge University Press.
20. Geison, Gerald L. 1995. The Private Science of Louis Pasteur. Princeton: Princeton University Press.
21. Ginzberg, Eli, and Anna B. Dutka. 1989. The Financing of Biomedical Research. Baltimore: Johns Hopkins University Press.
22. Goozner, Merrill. 2004. The $800 Million Pill: The Truth behind the Cost of New Drugs. Berkeley: University of California Press.
23. Greenberg, Daniel S. 2001. Science, Money, and Politics: Political Triumph and Ethical Erosion. Chicago: University of Chicago Press.
24. Gross, Cary P., G. F. Anderson, and N. R. Powe. 1999. The Relation between Funding by the National Institutes of Health and the Burden of Disease. New England Journal of Medicine 340, no. 24:1881-1887.
25. Hughes, Sally Smith. 2001. Making Dollars Out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980. Isis 92:541-575.
26. Jones, Kenneth Macdonald. 1976. The Endless Frontier. Prologue 8, no. 1:35-46.
27. Kassirer, Jerome. 2004. On the Take: How Big Business Is Corrupting American Medicine. New York: Oxford University Press.
28. Kingston, William. 2000. Antibiotics, Invention, and Innovation. Research Policy 29:679-710.
29. Kitcher, Philip. 2003. Science, Truth, and Democracy. New York: Oxford University Press.
30. Köhler, Georges J. F., and César Milstein. 1975. Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity. Nature 256, no. 5517:495-497.
31. Kohler, Robert E. 1991. Partners in Science: Foundations and Natural Scientists, 1900-1945. Chicago: University of Chicago Press.
32. Mandel, Richard. 1996. Half a Century of Peer Review: History of the Division of Research Grants 1946-1996. Bethesda, MD: National Institutes of Health, Division of Research Grants.
33. Mansfield, Edwin. 1991. Academic Research and Industrial Innovation. Research Policy 20 February: 1-12.
34. -. 1995. Academic Research Underlying Industrial Innovations: Sources, Characteristics, and Financing. Review of Economics and Statistics 77:55-65.
35. McGeary, Michael, and Philip M. Smith. 2002. Organizational Structure of the National Institutes of Health. Background paper for the National Academies' Committee on the Organizational Structure of the National Institutes of Health. Washington, DC: National Academy of Sciences.
36. Miles, Rufus, Jr. 1974. The Department of Health, Education, and Welfare. New York: Praeger.
37. Mowery, David C., Richard R. Nelson, Bhaven N. Sampat, and Arvids A. Ziedonis. 2004. Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act. Stanford, CA: Stanford Business Books.
38. Narin, Francis, and D. Olivastro. 1992. Status Report: Linkage between Technology and Science. Research Policy 21:237-249.
39. Narin, Francis, and R. P. Rozek. 1988. Bibliometric Analysis of U. S. Pharmaceutical Industry Research Performance. Research Policy 17, no. 3:139-154.
40. Neushul, Peter. 1993. Science, Government, and the Mass-Production of Penicillin. Journal of the History of Medicine and Allied Sciences 484:371-395.
41. Norberg, Arthur L., and Judy E. O'Neill. 1996. Transforming Computer Technology: Information Processing for the Pentagon, 1962-1986. Baltimore: Johns Hopkins University Press.
42. Office of Technology Assessment (OTA). 1984. Commercial Biotechnology: An International Analysis. OTA-BA-218, NTIS order #PB84-173608. Washington, DC: Government Printing Office. Also available at www.wws.princeton.edu/~ota/.
43. -. 1988. New Developments in Biotechnology. U. S. Investment in Biotechnology. OTA-BA-360, NTIS order #PB88-246939. Washington, DC: Government Printing Office. Also available at www.wws.princeton.edu/~ota/.
44. -. 1993. Pharmaceutical R&D: Costs, Risks, and Rewards. OTA-H-522. GPO stock #052-003-01315-1. NTIS order #PB93-163376. Washington, DC: Government Printing Office. Also available at www.wws.princeton.edu/~ota/.
45. Parascandola, John L. 1998. Public Health Service. In A Historical Guide to the U. S. Government, ed. G. T. Kurian, 487-493. New York: Oxford University Press. Also available at lhncbc.nlm.nih.gov/apdb/phsHistory/resources/phs-hist/pub-phs01.html.
46. Penick, James L., and Carroll W. Pursell, eds. 1972. Politics of American Science, 1939 to the Present. Revised ed. Cambridge, MA: MIT Press.
47. President's Scientific Research Board. 1947. Science and Public Policy. 4 Vols. Washington, DC: U. S. Government Printing Office.
48. Reingold, Nathan. 1987. Vannevar Bush's New Deal for Research; or, the Triumph of the Old Order. Historical Studies in the Physical and Biological Sciences 17, no. 2:299-344.
49. Rettig, Richard. 1977. Cancer Crusade: The Story of the National Cancer Act of 1971. Princeton: Princeton University Press.
50. Robinson, Judith. 2001. Noble Conspirator: Florence S. Mahoney and the Rise of the National Institutes of Health. Washington, DC: Francis Press.
51. Sapolsky, Harvey. 1990. Science and the Navy: The History of the Office of Naval Research. Princeton: Princeton University Press.
52. Shannon, James A. 1975. The Background of Some Contemporary Problems. Presented at Conference No. 3 on the Biomedical Sciences, Macy Foundation. Available at Office of NIH History, Building 31, Room 5B38, MSC 2092. Bethesda, MD: National Institutes of Health.
53. Shannon, James A., and Charles V. Kidd. 1961. Federal Support of Research Careers. Science. 134, no. 3488:1399-1402.
54. Smith, Jane S. 1990. Patenting the Sun: Polio and the Salk Vaccine. New York: William Morrow.
55. Starr, Paul. 1982. The Social Transformation of American Medicine. New York: Basic Books.
56. Strickland, Stephen P. 1972. Politics, Science, and Dread Disease: A Short History of United States Medical Research Policy. Cambridge, MA: Harvard University Press.
57. -. 1989. The Story of the NIH Grants Programs. Lanham, MD: University Press of America.
58. Swann, John P. 1988. Academic Scientists and the Pharmaceutical Industry: Cooperative Research in Twentieth Century America. Baltimore: Johns Hopkins University Press.
59. U. S. Bureau of the Census. 1975. Historical Statistics of the United States, Colonial Times to 1970. Washington, DC: U. S. Government Printing Office. Also available at www2.census.gov/prod2/statcomp/.
60. Vagelos, P. Roy, and Louis Galambos. 2003. Medicine, Science, and Merck. New York: Cambridge University Press.
61. Watson, James D., and F. H. C. Crick. 1953a. A Structure for Deoxyribonucleic Acid. Nature 171, no. 4356:737-738.
62. -. 1953b. Genetical Implications of the Structure of Deoxyribonucleic Acid. Nature 171, no. 4361:964-967.
63. White, Robert P. 2002. History of the Air Force Office of Scientific Research. OSR Brief 0108. Arlington, VA: Air Force Office of Scientific Research. www.afrlhorizons.com/Briefs/Mar02/OSR0108.html (accessed 27 June 2005).
64. Willman, David. 2003. Stealth Merger: Drug Companies and Government Medical Research. Los Angeles Times, 7 December.
65. -. 2004. National Institutes of Health: Public Servant or Private Marketeer? Los Angeles Times, 22 December.
66. Wilson, John Rowan. 1963. Margin of Safety. Garden City, NJ: Doubleday.
67. Zachary, G. Pascal. 1997. Endless Frontier: Vannevar Bush, Engineer of the American Century. New York: Free Press.